spacer
home > ict > autumn 2009 > liability insurance: protection in the clinical trial setting
PUBLICATIONS
International Clinical Trials

Liability Insurance: Protection in the Clinical Trial Setting

 

Product liability insurance, in its purest form, does not normally include the liability of an unproven, unregulated product in its testing stages. Usually, this is not a problem for manufacturers, since products are not distributed until the company and regulators feel the products are safe under normal use circumstances.

In the case of pharmaceuticals, medical devices or diagnostics, this is not the case. Testing is normally conducted in phases that can span years. Especially in the later phases of testing during clinical trials, there may be significant, uninsured liabilities incurred by the drug sponsor. These potential liabilities have created the need for clinical trials liability insurance. While sometimes referred to as ‘products liability’, their intent is to restrict coverage to the trial itself.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
5
     

There are no comments in regards to this article.

spacer
Harry Wallace is the Practice Leader for RCM&D’s Life Science and High Technology Group where he oversees the delivery of risk management products and services to these industries. He has over 30 years of experience in the insurance industry. Prior to becoming a broker, he was employed by the Chubb Group of Insurance Companies for 21 years where he held several senior level and management positions. Harry is a graduate of Texas A&M University. He holds a Certified Insurance Counselor designation and is a member of the Professional Liability Underwriting Society. Harry was recently recognised as one of six ‘Power Brokers’ for 2009 by Risk and Insurance magazine in the area of pharmaceuticals.
spacer
Harry Wallace
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

PCI Pharma Services Announces Organization Updates

Philadelphia, PA – May 20, 2019 – PCI Pharma Services, a leading biopharmaceutical outsourcing services provider, is pleased to announce the following management updates to help drive the company’s future vision, strategy and growth.
More info >>

White Papers

Bringing more control to temperature-sensitive logistics

UPS Supply Chain Solutions

By 2016, world sales of cold-chain drugs and biologics such as vaccines and blood plasma products will near $240 billion1. The increase has led to a surge in discussion about how to protect these products throughout the transportation logistics cycle. Industry experts are recommending that the term “cold chain” be eliminated from rules, guidance and best-practice documents. “Cold chain” now includes a broader spectrum of temperature ranges, such as controlled room temperature (CRT). This white paper focuses on the initial steps required to establish a temperature-sensitive supply chain.
More info >>

 
Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement